Search

everythinglearnresearchcommunity

for

Search:↓

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Anti-CD19 therapy may help treat SLE and NMOSD.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Atypical symptoms in lupus can indicate different kidney issues.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

New treatments and understanding of skin lupus are emerging in 2024.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

The man was diagnosed with lupus and improved with treatment.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Adalimumab improved folliculitis decalvans in most patients.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.